Uberti-Foppa C - Search Results

1

Pharmacotherapeutic management of HIV in transplant patients.

Spagnuolo V, Uberti-Foppa C, Castagna A. Spagnuolo V, et al. Expert Opin Pharmacother. 2019 Jul;20(10):1235-1250. doi: 10.1080/14656566.2019.1612364. Epub 2019 May 13. Expert Opin Pharmacother. 2019. PMID: 31081726 Review.

2

Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment.

Seminari E, De Bona A, Gentilini G, Galli L, Schira G, Gianotti N, Uberti-Foppa C, Soldarini A, Dorigatti F, Lazzarin A, Castagna A. Seminari E, et al. J Antimicrob Chemother. 2007 Oct;60(4):831-6. doi: 10.1093/jac/dkm282. Epub 2007 Aug 7. J Antimicrob Chemother. 2007. PMID: 17684056

3

Liver function parameters in HIV/HCV co-infected patients treated with amprenavir and ritonavir and correlation with plasma levels.

Spagnuolo V, Gentilini G, De Bona A, Galli L, Uberti-Foppa C, Soldarini A, Dorigatti F, Seminari E. Spagnuolo V, et al. New Microbiol. 2007 Jul;30(3):279-82. New Microbiol. 2007. PMID: 17802909 Free article.

4

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.

Morsica G, Bagaglio S, Cicconi P, Capobianchi MR, Pellizzer G, Caramello P, Orani A, Moioli C, Rizzardini G, Uberti-Foppa C, Puoti M, Monforte AD; Hepa I.C.o.N.A the Icona Foundation Study Groups. Morsica G, et al. J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):574-81. doi: 10.1097/QAI.0b013e3181add592. J Acquir Immune Defic Syndr. 2009. PMID: 19590432

5

Survival outcomes and effect of early vs. deferred cART among HIV-infected patients diagnosed at the time of an AIDS-defining event: a cohort analysis.

Miro JM, Manzardo C, Mussini C, Johnson M, d'Arminio Monforte A, Antinori A, Gill MJ, Sighinolfi L, Uberti-Foppa C, Borghi V, Sabin C; Late Presenters Investigators. Miro JM, et al. PLoS One. 2011;6(10):e26009. doi: 10.1371/journal.pone.0026009. Epub 2011 Oct 17. PLoS One. 2011. PMID: 22043301 Free PMC article.

6

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.

Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S, Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Liver Int. 2013 Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28. Liver Int. 2013. PMID: 23534616

7

Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease.

Armignacco O, Andreoni M, Sagnelli E, Puoti M, Bruno R, Gaeta GB, Perno CF, Santantonio TA, Bonfanti P, Bonora S, Borderi M, Castagna A, d'Arminio Monforte A, De Luca A, Grossi P, Guaraldi G, Maggiolo F, Mussini C, Sagnelli C, Tavio M, Torti C, Uberti-Foppa C, Andreoni M, Angarano G, Antinori A, Armignacco O, Carosi G, Chirianni A, Di Perri G, Galli M, Lazzarin A, Rizzardini G, Sagnelli E, Taliani G. Armignacco O, et al. New Microbiol. 2014 Oct;37(4):423-38. Epub 2014 Oct 1. New Microbiol. 2014. PMID: 25387281 Free article.

8

Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.

Merli M, Galli L, Castagna A, Salpietro S, Gianotti N, Messina E, Poli A, Morsica G, Bagaglio S, Cernuschi M, Bigoloni A, Uberti-Foppa C, Lazzarin A, Hasson H. Merli M, et al. New Microbiol. 2016 Apr;39(2):110-3. New Microbiol. 2016. PMID: 27196548 Free article.

9

Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.

Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D'Avolio A, Lazzarin A, Bonora S, Hasson H. Merli M, et al. J Antimicrob Chemother. 2017 Mar 1;72(3):812-815. doi: 10.1093/jac/dkw492. J Antimicrob Chemother. 2017. PMID: 27999010

10

Dynamic change in the NS3 protease domain in HIV/HCV-coinfected patients naïve to anti-HCV protease inhibitors.

Bagaglio S, Messina E, Hasson H, Merli M, Andolina A, Lazzarin A, Uberti-Foppa C, Morsica G. Bagaglio S, et al. New Microbiol. 2017 Jan;40(1):53-55. Epub 2017 Jan 5. New Microbiol. 2017. PMID: 28072886 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page